
WristArt โ
Interconnected wrist prosthesis components designed for joint replacement while conserving bone stock. [1]
Clinical developmentFirst-in-human implantation reported by Fibioseq.
Israeli developer of the WristArt total wrist replacement implant.
Fibioseq Medical develops implants for orthopedic extremity reconstruction. Its WristArt program targets painful wrist conditions in which joint replacement may offer an alternative to fusion. The company is based in Acre, Israel.
WristArt uses interconnected implant components designed to preserve bone and accommodate wrist biomechanics. Fibioseq reports the initiation of a first-in-human clinical study and a first implantation. The program remains a clinical-development offering; the reported procedure is separate from routine commercial availability.
Fibioseq reports first-in-human use of WristArt. The wrist replacement program is in clinical development. [1]
Latest recorded source review: 2026-10-30.
Scope: selected product families.
Device platforms are in clinical development.

Interconnected wrist prosthesis components designed for joint replacement while conserving bone stock. [1]
Clinical developmentFirst-in-human implantation reported by Fibioseq.
Accessed 10/30/2026
Last substantive review: 10/30/2026